GoodRx Holdings (GDRX) Capital Expenditures (2019 - 2026)
GoodRx Holdings recorded quarterly Capital Expenditures of $20.5 million in Q1 2026, up 40.57% quarter-over-quarter from $14.6 million in Q4 2025, and down 5.64% year-over-year from $21.7 million in Q1 2025.
GoodRx Holdings' Capital Expenditures history runs 8 years deep, the most recent figure standing at $20.5 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 5.64% year-over-year to $20.5 million; the TTM figure through Mar 2026 stood at $69.3 million (up 206.97% YoY), while the FY2025 annual figure was $70.5 million, up 5585.4% from the prior year.
- Capital Expenditures came in at $20.5 million for Q1 2026 at GoodRx Holdings, up from $14.6 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $55.4 million in Q3 2025 to a low of -$21.2 million in Q2 2025.
- A 5-year average of $8.9 million and a median of $645000.0 in 2022 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 13641.44% in 2025 and fell as far as 8011.19% in 2025.
- GoodRx Holdings' Capital Expenditures stood at $150000.0 in 2022, then jumped by 8208.67% to $12.5 million in 2023, then plunged by 98.7% to $162000.0 in 2024, then jumped by 8905.56% to $14.6 million in 2025, then soared by 40.57% to $20.5 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $20.5 million, $14.6 million, and $55.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 7.03 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 28,000.00 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 2.25 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 15.33 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 118,000.00 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 12.44 Mn |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | 20.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.51 Mn |
| Mar 31, 2026 | 20.51 Mn |
| Dec 31, 2025 | 14.59 Mn |
| Dec 31, 2025 | 14.59 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Jun 30, 2025 | -21.20 Mn |
| Jun 30, 2025 | -21.20 Mn |
| Mar 31, 2025 | 21.73 Mn |
| Mar 31, 2025 | 21.73 Mn |
| Dec 31, 2024 | 162,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 407,000.00 |
| Mar 31, 2024 | 407,000.00 |
| Dec 31, 2023 | 12.46 Mn |
| Dec 31, 2023 | 12.46 Mn |
| Sep 30, 2023 | 13.45 Mn |
| Sep 30, 2023 | 13.45 Mn |
| Jun 30, 2023 | 28.66 Mn |
| Jun 30, 2023 | 28.66 Mn |
| Mar 31, 2023 | 148,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | 645,000.00 |
| Sep 30, 2022 | 645,000.00 |
| Jun 30, 2022 | -7.51 Mn |
| Jun 30, 2022 | -7.51 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Dec 31, 2021 | 8.45 Mn |
| Dec 31, 2021 | 8.45 Mn |
| Sep 30, 2021 | 7.80 Mn |
| Sep 30, 2021 | 7.80 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Mar 31, 2021 | 6.98 Mn |
| Mar 31, 2021 | 6.98 Mn |
| Dec 31, 2020 | 4.87 Mn |
| Dec 31, 2020 | 4.87 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 5.87 Mn |
| Jun 30, 2020 | 5.87 Mn |
| Mar 31, 2020 | 674,000.00 |
| Mar 31, 2020 | 674,000.00 |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |